Stryker price target raised to $63 from $59 at RW Baird Baird raised its price target on Stryker following pre-announced Q4 results. The firm noted its solid organic growth in orthopedic implants and believes the company;s long term earnings growth targets remain achievable. Shares are Outperform rated.
News For SYK From The Last 14 Days
Check below for free stories on SYK the last two weeks.